» Articles » PMID: 28700535

Vitamin D Status Is Associated with Hepcidin and Hemoglobin Concentrations in Children with Inflammatory Bowel Disease

Overview
Specialty Gastroenterology
Date 2017 Jul 13
PMID 28700535
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Anemia, iron deficiency, and hypovitaminosis D are well-known comorbidities in inflammatory bowel disease (IBD). Epidemiologic studies have linked vitamin D deficiency with increased risk of anemia, and in vitro studies suggest that vitamin D may improve iron recycling through downregulatory effects on hepcidin and proinflammatory cytokines.

Methods: We aimed to investigate the association of vitamin D status with inflammation, iron biomarkers, and anemia in pediatric IBD. Cross-sectional data were obtained from N = 69 patients with IBD aged 5 to <19 years. Iron biomarkers (ferritin, soluble transferrin receptor), and 25-hydroxyvitamin D (25(OH)D), inflammatory biomarkers (C-reactive protein and α-1-acid glycoprotein), hepcidin, and hemoglobin were collected. Iron biomarkers were regression corrected for inflammation. Multivariable logistic/linear models were used to examine the associations of 25(OH)D with inflammation, iron status, hepcidin, and anemia.

Results: Approximately 50% of subjects were inflamed (C-reactive protein >5 mg/L or α-1-acid glycoprotein >1 g/L). Iron deficiency prevalence (inflammation-corrected ferritin <15 μg/L or soluble transferrin receptor >8.3 mg/L) was 67%; anemia was 36%, and vitamin D insufficiency (25(OH)D <30 ng/mL) was 77%. In linear regression models, vitamin D insufficiency was associated with increased hepcidin levels (β [SE] = 0.6 [0.2], P = 0.01) and reduced hemoglobin (β [SE] = -0.9 [0.5], P = 0.046), controlling for age, sex, race, insurance status, body mass index for age, inflammation, disease diagnosis (ulcerative colitis versus Crohn's disease), and disease duration, compared with 25(OH)D ≥30 ng/mL.

Conclusions: Our results suggest that concentrations of 25(OH)D ≥30 ng/mL are associated with lower hepcidin and higher hemoglobin levels. Further research is needed to clarify the association of vitamin D with inflammation, iron status, and anemia in pediatric IBD.

Citing Articles

Micronutrient deficiencies in older patients with inflammatory bowel disease are not associated with worse adverse clinical outcome rates.

Andres B, Rasool A, Pepich G, Hsu C, Taleban S Ann Gastroenterol. 2024; 37(5):536-542.

PMID: 39238798 PMC: 11372540. DOI: 10.20524/aog.2024.0900.


The interplay between vitamin D status, subclinical inflammation, and prediabetes.

Arabi A, Nasrallah D, Mohsen S, Abugharbieh L, Al-Hashimi D, AlMass S Heliyon. 2024; 10(15):e35764.

PMID: 39170232 PMC: 11337041. DOI: 10.1016/j.heliyon.2024.e35764.


Nutritional Modulation of Hepcidin in the Treatment of Various Anemic States.

DAndrea P, Giampieri F, Battino M Nutrients. 2023; 15(24).

PMID: 38140340 PMC: 10745534. DOI: 10.3390/nu15245081.


Characteristics of the Inflammatory Bowel Disease in Children: A Croatian Single-Centre Retrospective Study.

Pivac I, Jelicic Kadic A, Despot R, Zitko V, Tudor D, Runjic E Children (Basel). 2023; 10(10).

PMID: 37892340 PMC: 10605261. DOI: 10.3390/children10101677.


The association between vitamin D status and inflammatory bowel disease among children and adolescents: A systematic review and meta-analysis.

Fatahi S, Alyahyawi N, Albadawi N, Mardali F, Dara N, Sohouli M Front Nutr. 2023; 9:1007725.

PMID: 36698467 PMC: 9868587. DOI: 10.3389/fnut.2022.1007725.


References
1.
Rabizadeh S, Dubinsky M . Update in pediatric inflammatory bowel disease. Rheum Dis Clin North Am. 2013; 39(4):789-99. PMC: 3817417. DOI: 10.1016/j.rdc.2013.03.010. View

2.
McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B . Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public Health Nutr. 2008; 12(4):444-54. DOI: 10.1017/S1368980008002401. View

3.
Zittermann A, Jungvogel A, Prokop S, Kuhn J, Dreier J, Fuchs U . Vitamin D deficiency is an independent predictor of anemia in end-stage heart failure. Clin Res Cardiol. 2011; 100(9):781-8. DOI: 10.1007/s00392-011-0312-5. View

4.
Holick M, Binkley N, Bischoff-Ferrari H, Gordon C, Hanley D, Heaney R . Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96(7):1911-30. DOI: 10.1210/jc.2011-0385. View

5.
Bacchetta J, Zaritsky J, Sea J, Chun R, Lisse T, Zavala K . Suppression of iron-regulatory hepcidin by vitamin D. J Am Soc Nephrol. 2013; 25(3):564-72. PMC: 3935584. DOI: 10.1681/ASN.2013040355. View